{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:34:57Z","timestamp":1792550097808,"version":"4.5.0"},"reference-count":45,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s253232","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:19:35Z","timestamp":1588540775000},"page":"1693-1704","source":"Crossref","is-referenced-by-count":181,"title":["<p>Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development<\/p>"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Brooke","family":"Benner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7310-5098","authenticated-orcid":true,"given":"Logan","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3388-7069","authenticated-orcid":true,"given":"Dionisia","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4429-961X","authenticated-orcid":true,"given":"Mahmoud","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0380-2012","authenticated-orcid":true,"given":"Mathew A","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2688-0486","authenticated-orcid":true,"given":"Sagar","family":"Sardesai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wesolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1411366","volume":"373","author":"Tap","year":"2015","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(19)30764-0","volume":"394","author":"Tap","year":"2019","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13569-018-0101-2","volume":"8","author":"Giustini","year":"2018","journal-title":"Clin Sarcoma Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3899\/jrheum.160816","volume":"44","author":"Ehrenstein","year":"2017","journal-title":"J Rheumatol"},{"key":"ref5","author":"Granowitz","year":"1976","journal-title":"Clin Orthop Relat Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1002\/cncr.26529","volume":"118","author":"Griffin","year":"2012","journal-title":"Cancer"},{"key":"ref7","volume-title":"A Landscape Effect in Tenosynovial Giant-Cell Tumor from Activation of CSF1 Expression by a Translocation in a Minority of Tumor Cells","year":"2005"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0b013e31802b86f8","volume":"31","author":"Cupp","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"a021857","DOI":"10.1101\/cshperspect.a021857","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","volume":"5","author":"Cannarile","year":"2017","journal-title":"J Immunother Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.cellsig.2009.04.003","volume":"21","author":"Chang","year":"2009","journal-title":"Cell Signal"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/S0021-9258(17)40265-1","volume":"252","author":"Stanley","year":"1977","journal-title":"J Biol Chem"},{"key":"ref13","first-page":"33","volume":"41","author":"Breton","year":"2014","journal-title":"Immunity"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","volume":"36","author":"Ostuni","year":"2015","journal-title":"Trends Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nri2528","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coi.2005.11.006","volume":"18","author":"Chitu","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1182\/blood-2012-04-425595","volume":"120","author":"Chitu","year":"2012","journal-title":"Blood"},{"key":"ref18","unstructured":"Sankyo D. TURALIO (pexidartinib) prescribing information."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028.Leukocyte","volume":"1","author":"Denardo","year":"2011","journal-title":"Cancer Discov"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1158\/0008-5472.CAN-12-3981","volume":"73","author":"Xu","year":"2013","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/neuonc\/nov272","volume":"18","author":"Stafford","year":"2016","journal-title":"Neuro Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1177\/0271678X16666551","volume":"37","author":"Li","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1097\/j.pain.0000000000000228","volume":"156","author":"Thompson","year":"2015","journal-title":"Pain"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1038\/onc.2017.261","volume":"36","author":"Yan","year":"2017","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/pros.21277","volume":"71","author":"Thudi","year":"2011","journal-title":"Prostate"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/pros.20776","volume":"68","author":"Thudi","year":"2008","journal-title":"Prostate"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"9426","DOI":"10.1158\/0008-5472.CAN-05-0826","volume":"65","author":"Halvorson","year":"2005","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10637-019-00745-z","author":"Lee","year":"2019","journal-title":"Invest New Drugs"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"10546","DOI":"10.1200\/JCO.2017.35.15_suppl.10546","volume":"35","author":"Hittson","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1684\/ejd.2016.2844","volume":"26","author":"Ricci","year":"2016","journal-title":"Eur J Dermatology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"175883591985423","DOI":"10.1177\/1758835919854238","volume":"11","author":"Wesolowski","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-3083.2007.02051.x","volume":"67","author":"Skrzeczy\u0144ska-Moncznik","year":"2008","journal-title":"Scand J Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s40257-017-0292-y","volume":"18","author":"Grimaldi","year":"2017","journal-title":"Am. J. Clin. Dermatol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1634\/theoncologist.2019-0418","volume":"24","author":"Rosenbaum","year":"2019","journal-title":"Oncologist"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1200\/JCO.2019.37.15_suppl.2579","volume":"37","author":"Cassier","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref37","author":"Wainberg","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1200\/JCO.2018.36.15_suppl.2015","volume":"36","author":"Colman","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1182\/blood.V120.21.1638.1638","volume":"120","author":"Moskowitz","year":"2012","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2018.00247","volume":"9","author":"Lo","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e1149674","DOI":"10.1080\/2162402X.2016.1149674","volume":"5","author":"Buqu\u00e9","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/neuonc\/nov245","volume":"18","author":"Butowski","year":"2016","journal-title":"Neuro Oncol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","volume":"74","author":"Zhu","year":"2014","journal-title":"Cancer Res"},{"key":"ref44","first-page":"6218","volume":"19","author":"Bryant","year":"2009","journal-title":"Cancer Cell"},{"key":"ref45","unstructured":"Plexxikkon. Pexidartinib; 2019."}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=57824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=57824","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T10:06:16Z","timestamp":1615543576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/pexidartinib-a-novel-small-molecule-csf-1r-inhibitor-in-use-for-tenosy-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":45,"URL":"https:\/\/doi.org\/10.2147\/dddt.s253232","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}